An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?

BACKGROUND: When a medicine such as rofecoxib (Vioxx) is withdrawn, or a whole class of medicines discredited such as the selective COX-2 inhibitors (COX-2s), follow-up of impacts at consumer level can be difficult and costly. The Australian Longitudinal Study on Women's Health provides a rare...

Descripción completa

Detalles Bibliográficos
Autores principales: Parkinson, Lynne, Doljagore, Xenia, Gibson, Richard, Doran, Evan, Notley, Lisa, Stewart Williams, Jenny, Kowal, Paul, Byles, Julie E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280381/
https://www.ncbi.nlm.nih.gov/pubmed/22114865
http://dx.doi.org/10.1186/1471-2458-11-892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280381/
https://www.ncbi.nlm.nih.gov/pubmed/22114865
http://dx.doi.org/10.1186/1471-2458-11-892

Ejemplares similares